Investment
Features
FeesSafety
Academy
More
Pluang+

Medtronic's 49-year dividend streak continues as growth in cardiac ablation drives new investor interest.

Company Fundamentals
03 Oct 2026
24/7 Wall Street
View Source
Bullish
Medtronic's 49-year dividend streak continues as growth in cardiac ablation drives new investor interest.

Medtronic has maintained a 49-year streak of raising dividends, despite its stock losing 20% over five years. Recently, the company reported faster growth driven by its cardiac ablation business, which grew 88% globally and 139% in the U.S., signaling a shift from dividend income to growth potential. With a dividend yield of about 3.27% and solid cash flow coverage, the dividend remains a floor for investors, while innovations in ablation and other areas offer upside. The upcoming investor day in December will provide further insights on growth prospects and margin improvements.

Medtronic's stock price at USD 86.38 is closer to its 52-week low of USD 73.75 than its high of USD 105.35 as of Oct 03, 2026 18:31 WIB, showing some distance from its peak despite steady dividend increases. Its dividend yield of 3.33% on Pluang slightly exceeds the article's 3.27% figure, reflecting a consistent income stream amid a mostly selling sentiment with 97% of orders being sell. The typical hold time of 63 days suggests moderate investor engagement with the stock during this period.

More News (MDT)

Medtronic's Stealth AXiS™ and Corsano™ wearable named TIME Best Inventions of 2026

Medtronic's Stealth AXiS™ and Corsano™ wearable named TIME Best Inventions of 2026

Medtronic announced that its Stealth AXiS™ surgical system and Corsano™ multi-parameter wearable have been named to the TIME Best Inventions of 2026 list. The Stealth AXiS™ integrates planning, navigation, and robotic-assisted surgery into one platfo...

Others
Bullish
4 days ago
MiniMed forms new board as independent diabetes tech company post-Medtronic separation

MiniMed forms new board as independent diabetes tech company post-Medtronic separation

MiniMed announced its new Board of Directors following its separation from Medtronic, marking its start as an independent public company focused on diabetes technology. The board includes experts in healthcare, medtech, manufacturing, and governance,...

Company Fundamentals
Bullish
4 days ago
Five blue-chip stocks, including Procter & Gamble, have raised dividends for decades, rewarding patient investors.

Five blue-chip stocks, including Procter & Gamble, have raised dividends for decades, rewarding patient investors.

Procter & Gamble leads with 70 consecutive years of dividend increases, joined by T. Rowe Price, Cisco Systems, Medtronic, and Johnson & Johnson, all known for steady dividend growth backed by strong cash flow. These companies maintain payout ratios ...

Market News
Bullish
4 days ago
Three overlooked healthcare dividend stocks offer steady, growing payouts backed by strong cash flow.

Three overlooked healthcare dividend stocks offer steady, growing payouts backed by strong cash flow.

Medtronic, Becton Dickinson, and Abbott Laboratories are three healthcare stocks with modest yields that have consistently raised dividends for decades, even through economic downturns. Medtronic is nearing 50 years of dividend increases with a 3.06%...

Market News
Bullish
4 days ago
MiniMed completes separation from Medtronic, becoming fully independent in diabetes care.

MiniMed completes separation from Medtronic, becoming fully independent in diabetes care.

MiniMed has officially separated from Medtronic, marking its first day as an independent company focused on advancing diabetes care. Medtronic exchanged its shares for MiniMed stock and no longer holds equity in MiniMed. This independence allows Mini...

Company Fundamentals
Bullish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App